METTL1, as one of the key tRNA-modifying enzymes, has been extensively reported to promote cancer development by mediating tRNA m7G modifications in lung cancer, ICC, HCC, and bladder cancer (16–20). The gene discussed is METTL1; the disease is intrahepatic cholangiocarcinoma.